Viemed Healthcare Inc

Viemed Healthcare Inc(VMD)股票分析

$8.820

-0.186 (-2.11%)收盤時

Loading chart…
High
9.230
Open
9.020
VWAP
8.95
Vol
294.11K
Mkt Cap
251.17M
Low
8.785
Amount
2.63M
EV/EBITDA, TTM
6.47

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.

AI analysis of Viemed Healthcare Inc (VMD)

hold

Viemed Healthcare Inc is currently priced at $8.82, which is below the analyst price target of $14 from Barrington, indicating potential upside. However, the stock has a low RSI of 35.115, suggesting it may be oversold. The recent earnings report showed a GAAP EPS of $0.07, missing expectations, which may dampen investor sentiment. Additionally, insider selling has increased by 207.27%, indicating potential concerns among insiders. Therefore, while there is upside potential, the risks associated with recent performance and insider activity suggest a hold rather than a buy at this time.

估值指標

The current forward P/E ratio for Viemed Healthcare Inc (VMD) is 22.88, compared to its 5-year average forward P/E of 24.05.

Forward P/E

Fair
5Y Average P/E
24.05
Current P/E
22.88
高估
31.02
低估
17.07

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
6.07
Current EV/EBITDA
6.47
高估
7.42
低估
4.73

Forward P/S

Undervalued
5Y Average P/S
1.34
Current P/S
0.97
高估
1.69
低估
1.00

Alphio AI Price Scenarios for VMD

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%VMD

$9.49

情境價格

B

Base

Base · 50%VMD

$8.88

情境價格

B

Bear

Bear · 25%VMD

$7.16

情境價格

事件時間軸

2026-03-04 (ET)

16:50:00

Viemed Healthcare Authorizes Share Repurchase Program Through March 2027

2025-07-02 (ET)

08:43:56

Viemed Healthcare completes acquisition of Lehan's Medical Equipment

2025-06-09 (ET)

08:18:09

Viemed Healthcare board authorizes share repurchase program up to 5%

2025-05-06 (ET)

08:32:47

Viemed entered into definitive agreement to acquire Lehan's Medical Equipment

2025-03-10 (ET)

17:02:06

Viemed Healthcare sees FY25 revenue $254M-$265M, consensus $251.43M

資訊

VMD FAQ — answered by Alphio AI

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).

Viemed Healthcare Inc is currently priced at $8.82, which is below the analyst price target of $14 from Barrington, indicating potential upside. However, the stock has a low RSI of 35.115, suggesting it may be oversold. The recent earnings report showed a GAAP EPS of $0.07, missing expectations, which may dampen investor sentiment. Additionally, insider selling has increased by 207.27%, indicating potential concerns among insiders. Therefore, while there is upside potential, the risks associated with recent performance and insider activity suggest a hold rather than a buy at this time.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始